The U.S. Food and Drug Administration (FDA) has postponed making a decision on Lynparza for metastatic castration-resistant prostate cancer (mCRPC), which is...
AstraZeneca has signed a strategic partnership agreement with G42 Healthcare to manufacture medicinal therapies in Abu Dhabi. The agreement concentrates on teamwork...
In a letter shared with healthcare providers, AstraZeneca has announced that it will be pulling its leukemia antibody-drug conjugate Lumoxiti (moxetumomab pasudotox-tdfk)...
Ionis Pharmaceuticals and startup gene editing firm Metagenomi have just signed a multi-target research deal that has the potential to generate nearly...
Spectrum Laboratory Products has voluntarily recalled all batches of epinephrine USP, a bulk API powder utilized in the production of the pharmaceutical...
Omnichannel orchestration is critical to delivering a customized and relevant experience to each customer. If designed and executed correctly, responsive omnichannel marketing...
The U.S. Food and Drug Administration (FDA) has postponed making a decision on Lynparza for metastatic castration-resistant prostate cancer (mCRPC), which is...
AstraZeneca has signed a strategic partnership agreement with G42 Healthcare to manufacture medicinal therapies in Abu Dhabi. The agreement concentrates on teamwork...
In a letter shared with healthcare providers, AstraZeneca has announced that it will be pulling its leukemia antibody-drug conjugate Lumoxiti (moxetumomab pasudotox-tdfk)...
Ionis Pharmaceuticals and startup gene editing firm Metagenomi have just signed a multi-target research deal that has the potential to generate nearly...
Spectrum Laboratory Products has voluntarily recalled all batches of epinephrine USP, a bulk API powder utilized in the production of the pharmaceutical...
Omnichannel orchestration is critical to delivering a customized and relevant experience to each customer. If designed and executed correctly, responsive omnichannel marketing...
Trikafta was approved by FDA for the treatment of Cystic Fibrosis in patients aged 6 to 11 years, after receiving approval to be used in patients of ages 12 and up